Realize Therapeutics is a life sciences company developing microbiome solutions. Excessive antibiotics harm the gut microbiome, causing millions to lose key microbes and suffer gut dysbiosis resulting in chronic health problems.
Realize’s strategy is to develop, research, and commercialize solutions that restore core deficiencies in the human gut microbiome, based on licensed microbe technology from William Davis, MD.
Realize’s proprietary L. Reuteri LRDR™ core microbe technology and formulations have applications as medical nutrition, dietary supplements and potentially, as pharmaceuticals.
A revenue-stage business, Realize commercializes its branded products through multiple channels via distributors, strategic partners, and direct-to-consumer.
Company Details
- Employees
- 6
- Founded
- -
- Address
- 37 Sherwood Terrace, Lake Bluff,illinois 60044,united States
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- realizetherapeutics.com
- Keywords
- microbial therapeutics, cannabinoids, healthy-aging, wellbeing, Oxytocin, WheatBelly, endocannabinoids, L. Reuteri, obesity, weight management, functional medicine, mic, microbiome, nutrition.
- HQ
- Lake Bluff, Illinois
Realize Therapeutics Questions
Realize Therapeutics's website is realizetherapeutics.com
Realize Therapeutics's LinkedIn profile is https://www.linkedin.com/company/realize-therapeutics
Realize Therapeutics has
6 employees.
View email and phone details for 6
employees at Realize Therapeutics.
Realize Therapeutics's industry is
Biotechnology Research
Realize Therapeutics's top competitors are
Siolta Therapeutics,
Oncusp Therapeutics,
Rubius Therapeutics,
Ksq Therapeutics, Inc.,
Prelude Therapeutics,
Stelexis Biosciences, Inc.,
Eliksa Therapeutics,
Fekra Therapeutics,
Sorrento Therapeutics, Inc.,
Indaptus Therapeutics, Inc..
Realize Therapeutics's categories are Biotechnology Research
Realize Therapeutics's founding year is 2016
